Dr. Kohli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
600 S Dobson Rd
Bldg B
Chandler, AZ 85224Phone+1 480-686-8874Fax+1 480-686-8875- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2009 - 2011
- University of Virginia Medical CenterResidency, Internal Medicine, 2006 - 2009
- University of Virginia School of MedicineClass of 2006
Certifications & Licensure
- AZ State Medical License 2015 - 2026
- OH State Medical License 2023 - 2025
- MD State Medical License 2009 - 2016
- DC State Medical License 2012 - 2014
- VA State Medical License 2006 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Leukapheresis for Research on HCV-Coinfected Patients Start of enrollment: 2004 Jan 14
- Combination Therapy for Chronic Hepatitis C Infection Start of enrollment: 2013 Jan 01
- Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV Start of enrollment: 2014 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 26 citationsAldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial.Stephen A Harrison, Manal F Abdelmalek, Guy Neff, Nadege Gunn, Cynthia D Guy, Naim Alkhouri, Mustafa R Bashir, Bradley Freilich, Anita Kohli, Arun Khazanchi, Muhammad ...> ;The Lancet. Gastroenterology & Hepatology. 2022 Jul 1
- 66 citationsSafety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase I...Naim Alkhouri, Robert Herring, Heidi Kabler, Zeid Kayali, Tarek Hassanein, Anita Kohli, Ryan S Huss, Yanni Zhu, Andrew N Billin, Lars Holm Damgaard, Kristine Buchholtz...> ;Journal of Hepatology. 2022 Sep 1
- 15 citationsFenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat.Eric J Lawitz, Bal Raj Bhandari, Peter J Ruane, Anita Kohli, Eliza Harting, Dora Ding, Jen-Chieh Chuang, Ryan S Huss, Chuhan Chung, Robert P Myers, Rohit Loomba> ;Clinical Gastroenterology and Hepatology. 2023 Jan 1
- Join now to see all
Press Mentions
- Arizona on the Cutting Edge of Innovative Research ProgramsMarch 4th, 2022
- Merck’s Household Contacts Study Testing Molnupiravir Goes to a Connected Investigator in ArizonaSeptember 16th, 2021
- Regeneron Clinical Trials of COVID Antibody Drugs Featured in NY TimesAugust 18th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: